Association of systemic lupus erythematosus with promoter polymorphisms of the mannose-binding lectin gene

Arthritis and Rheumatism

Volumn 41, Issue 9, 1998, Pages 1663-1668

  Ip, W K ^a   Chan, S Y ^a   Lau, C S ^a   Lau, Y L ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

LECTIN; MANNOSE BINDING PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; CARRIER PROTEINS; CHILD; COLLECTINS; DNA PRIMERS; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; INFANT, NEWBORN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 0031682102     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Lachmann PJ. New aspects in inherited complement deficiencies. In: Chapel HM, Levinsky RJ, Webster AADB, editors. Progress in immune deficiency III. London: Royal Society of Medicine Services Limited; 1991. p. 17-9.
2. Walport MJ. The Roche Rheumatology Prize lecture -complement deficiency and disease. Br J Rheumatol 1993;32:269-73.
3. Fielder AHL, Walport MJ, Batchelor JR, Rynes RI, Black CM, Dodi IA, et al. Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. BMJ 1983;286:425-8.
4. Dunckley H, Gatenby PA, Hawkins B, Naito S, Serjeantson SW. Deficiency of C4A is a genetic determinant of systemic lupus erythematosus in three ethnic groups. J Immunogenet 1987;14: 209-18.
5. Kumar A, Kumar P, Schur PH. DR3 and non-DR3 associated complement component C4A deficiency in systemic lupus erythematosus. Clin Immunol Immunopathol 1991;60:55-64.
6. Lachmann PJ. Complement deficiency and the pathogenesis of autoimmune immune complex disease. Chem Immunol 1990;49: 245-63.
7. Pilkington C, Yeung E, Isenberg D, Lefvert AK, Rook GA. Agalactosyl IgG and antibody specificity in rheumatoid arthritis, tuberculosis, systemic lupus erythematosus and myasthenia gravis. Autoimmunity 1995;22:107-11.
8. Groenink J, Spijker J, van den Henrik Oudijk IE, Boeije L, Rook G, Aarden L, et al. On the interaction between agalactosyl IgG and Fcγ receptors. Eur J Immunol 1996;26:1404-7.
9. Duits AJ, Bootsma H, Derksen RHWM, Spronk PE, Kater L, Kallenberg CGM, et al. Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum 1995;38:1832-6.
10. Enenkel B, Jung D, Frey J. Molecular basis of IgG Fc receptor III defect in a patients with systemic lupus erythematosus. Eur J Immunol 1991;21:659-63.
11. Salmon JE, Millard S, Schachter LA, Arnett FC, Ginzler EM, Gourley MF, et al. FcγRIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 1996;97:1348-54.
12. Wild J, Robinson D, Winchester B. Isolation of mannose-binding proteins from human and rat liver. Biochem J 1983;210:167-74.
13. Thiel S, Holmskov U, Hviid L, Laursen SB, Jensenius JC. The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clin Exp Immunol 1992;90:31-5.
14. Malhotra R, Thiel S, Reid KMB, Sim RB. Human leukocyte C1q receptor binds other soluble proteins with collagen domains. J Exp Med 1990;172:955-9.
15. Taylor ME, Brickell PM, Craig RK, Summerfield JA. Structure and evolutionary origin of the gene encoding a human serum mannose-binding protein. Biochem J 1989;262:763-71.
16. Kuhlman M, Joiner K, Ezekowiz RA. The human mannose-binding protein functions as an opsonin. J Exp Med 1989;169: 1733-45.
17. Super M, Levinsky RJ, Turner MW. The level of mannan-binding protein regulates the binding of complement-derived opsonins to mannan and zymosan at low serum concentrations. Clin Exp Immunol 1990;79:144-50.
18. Turner MW. Deficiency of mannan binding protein - a new complement deficiency syndrome. Clin Exp Immunol 1991;86 Suppl 1:53-6.
19. Anders EM, Hartley CA, Reading PC, Ezekowitz RA. Complement-dependent neutralization of influenza virus by serum mannose-binding lectin. J Gen Virol 1994;75:615-22.
20. Matsushita M, Fujita T. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1-like serine protease. J Exp Med 1992;176:1497-502.
21. Sato T, Endo Y, Matsushita M, Fujita T. Molecular characterization of a novel serine protease involved in activation of the complement system by mannose-binding protein. Int Immunol 1994;6:665-9.
22. Fujita T, Taira S, Kodama N, Matsushita M, Fujita T. Mannose-binding protein recognizes glioma cells: in vitro analysis of complement activation on glioma cells via the lectin pathway. Jpn J Cancer Res 1995;86:187-92.
23. Sumiya M, Super M, Tabona P, Levinsky RJ, Arai T, Turner MW, et al. Molecular basis of opsonin defect in immunodeficient children. Lancet 1991;337:1569-70.
24. Madsen HO, Garred P, Kurtzhals JAL, Lamm LU, Ryder LP, Thiel S. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics 1994;40:37-44.
25. Lipscombe RJ, Sumiya M, Hill AVS, Lau YL, Levinsky RJ, Summerfield JA, et al. High frequencies in African and non-African populations of independent mutations in the mannose binding protein. Hum Mol Genet 1992;9:709-15.
26. Garred P, Thiel S, Madsen HO, Ryder LP, Jensenius JC, Svejgaard A. Gene frequency and partial protein characterization of an allelic variant of mannan binding protein associated with low serum concentrations. Clin Exp Immunol 1992;90:517-21.
27. Garred P, Madsen HO, Kurtzhals JAL, Lamm LU, Thiel S, Hey AS, et al. Diallelic polymorphism may explain variations of the blood concentration of mannan-binding protein in Eskimos, but not in black Africans. Eur J Immunogenet 1992;19:403-12.
28. Lipscombe RJ, Sumiya M, Summerfield JA, Turner MW. Distinct physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype. Immunology 1995;85:660-7.
29. Lipscombe RJ, Beatty DW, Ganczakowski M, Goddard EA, Jenkin T, Lau YL, et al. Mutation in the human mannose-binding protein gene: frequencies in several population groups. Eur J Hum Genet 1996;4:13-9.
30. Madsen HO, Garred P, Thiel S, Kurtzhals JAL, Lamm LU, Ryder LP, et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995;155:3013-20.
31. Super M, Thiel S, Lu J, Levinsky RJ, Turner MW. Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet 1989;ii:1236-9.
32. Garred P, Madsen HO, Hofmann B, Svejgaard A. Increased frequency of homozygosity of abnormal mannan-binding protein alleles immunodeficiency. Lancet 1995;346:941-3.
33. Summerfield JA, Ryder S, Sumiya M, Thursz M, Gorchein A, Monteil MA, et al. Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet 1995;345:886-9.
34. Garred P, Madsen HO, Balslev U, Hofmann B, Pedersen C, Gerstoft J, et al. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet 1997;349:236-40.
35. Davies EJ, Snowden N, Hillarby MC, Carthy D, Grennan DM, Thomson W, et al. Mannose-binding protein gene polymorphism in systemic lupus erythematosus. Arthritis Rheum 1995;38:110-4.
36. Lau YL, Lau CS, Chan SY, Karlberg J, Turner MW. Mannose-binding protein in Chinese patients with systemic lupus erythematosus. Arthritis Rheum 1996;39:706-8.
37. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
38. Bohme J, Owerbach D, Denaro M, Lernmark A, Peterson PA, Rask L. Human class II major histocompatibility antigen β-chains are derived from at least three loci. Nature 1983;301:82-4.
39. Lau YL, Chan SY, Turner MW, Fong J, Karlberg J. Mannose-binding protein in preterm infants: developmental profile and clinical significance. Clin Exp Immunol 1995;102:649-54.
40. Kotzin B. Systemic lupus erythematosus. Cell 1996;85:303-6.
41. Chan YT. Systemic lupus erythematosus. In: Ho CS, Wu PC, editors. Topics in pathology for Hong Kong. Hong Kong: Hong Kong University Press; 1995. p. 67-73.
42. Summerfield JA, Sumiya M, Levin M, Turner MW. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ 1997;314:1229-32.